Key Points
- CEO Sean Duffy sold 17,258 Omada Health shares at an average price of $20.68, generating approximately $356,895. He retained 382,594 shares after the transaction, reducing his ownership by 4.32%.
- Omada Health recently exceeded quarterly expectations, reporting $0.08 in EPS versus estimates of a $0.02 loss and revenue of $87.83 million, above the $80.93 million consensus forecast.
- Analyst sentiment remains broadly positive, with a “Moderate Buy” consensus and an average price target of $26.67, while several institutional investors—including BlackRock—have established new positions.
Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CEO Sean Duffy sold 17,258 shares of the business's stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $20.68, for a total transaction of $356,895.44. Following the completion of the transaction, the chief executive officer owned 382,594 shares in the company, valued at approximately $7,912,043.92. The trade was a 4.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Omada Health Trading Up 2.8%
Omada Health stock opened at $20.95 on Tuesday. Omada Health, Inc. has a 12 month low of $10.28 and a 12 month high of $26.92. The business's 50 day simple moving average is $21.80 and its 200 day simple moving average is $18.73. The company has a market cap of $1.28 billion, a price-to-earnings ratio of 419.00 and a beta of 2.03.
Omada Health (NASDAQ:OMDA - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.02) by $0.10. The business had revenue of $87.83 million during the quarter, compared to the consensus estimate of $80.93 million. Omada Health had a return on equity of 2.60% and a net margin of 1.39%. As a group, equities research analysts forecast that Omada Health, Inc. will post 0.09 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on OMDA. Citigroup reaffirmed an "outperform" rating on shares of Omada Health in a report on Friday, August 14th. JPMorgan Chase & Co. lifted their target price on shares of Omada Health from $26.00 to $30.00 and gave the stock an "overweight" rating in a research note on Friday, August 14th. BTIG Research restated a "buy" rating and set a $35.00 price target on shares of Omada Health in a research note on Friday, September 11th. Weiss Ratings upgraded shares of Omada Health from a "sell (e+)" rating to a "sell (d+)" rating in a research note on Tuesday, August 11th. Finally, Wall Street Zen cut shares of Omada Health from a "buy" rating to a "hold" rating in a report on Saturday. Eleven equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $26.67.
Get Our Latest Analysis on Omada Health
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in OMDA. BlackRock Inc. purchased a new position in Omada Health during the second quarter valued at approximately $48,775,000. SG Americas Securities LLC purchased a new stake in Omada Health in the 1st quarter worth approximately $10,401,000. Jefferies Financial Group Inc. bought a new position in Omada Health in the 2nd quarter valued at $15,016,000. Madryn Asset Management LP bought a new position in Omada Health in the 2nd quarter valued at $12,814,410. Finally, Walleye Capital LLC purchased a new position in shares of Omada Health during the 2nd quarter valued at $11,648,000.
Omada Health Company Profile
(
Get Free Report)
Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines connected health devices, digital tools, health coaching and clinical support to help members improve their health and manage conditions such as diabetes, hypertension and musculoskeletal disorders.
The company's services are designed for employers, health plans and other healthcare organizations seeking to support populations with ongoing healthcare needs.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
